Brief: Ceapro says qtrly earnings per share $0.00
15/11/2017 14:05
Nov 15 (Reuters) - Ceapro Inc CZO.V -
* Ceapro reports 2017 third quarter business update and
financial
results
* Q3 sales C$3.6 million versus C$3.018 million
* Ceapro Inc qtrly earnings per share $0.00
* Ceapro Inc - results from animal studies evaluating
bioavailability of impregnated COQ10 with beta glucan expected
Q1 2018
Source text for Eikon: ID:nCCNgLZWla
Further company coverage: CZO.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Ceapro
See all newsBrief: Aeterna Zentaris Announces Details Regarding Transaction with Ceapro
Brief: Ceapro Receives Final Court Approval For Merger With Aeterna Zentaris
Brief: Aeterna Zentaris And Ceapro Announce Merger Of Equals To Create Diversified Biopharmaceutical Company
Brief: Ceapro Inc. Reports 2023 Third Quarter And Nine-Month Financial Results And Operational Highlights
Brief: Ceapro Initiates Phase 1-2A Study Assessing Avenanthramides For Potential Applications In Inflammation Based Diseases